Pulished Date August, 2019
ID: 850
Share on
Share on

Asia Pacific Bovine Respiratory Disease Treatment Market Analysis - By Type Of Treatment (Anti-Infectious Agents (antibiotics And Sulfas), Anti-Parasiticides, Bronchodilators, Oral Rehydration Fluids, Non-Steroidal Anti-Inflammatories, And Mucolytic), And By Country (India, China, South Korea, Australia, Japan and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: August, 2019
ID: 850
Pages: 140

Asia Pacific Bovine Respiratory Disease Treatment Market Size and Growth Rate (2018-2023):

The Asia Pacific Bovine Respiratory Disease Treatment Market has been estimated at USD 5.87 million in 2018 and is projected to reach USD 21.85 million by 2023, at a CAGR of 30.05% during the forecast period from 2018 to 2023.  In the Asia Pacific region, China and India have greater cattle adoption and are expected to grow fast.

Asia Pacific Bovine Respiratory Disease Treatment Market – Drivers and Restraints:

BRD is more than just a disease. It’s a respiratory disease complex which combines disease organisms with management and environment stressors. There are a number of built-in stressors such as transition stress, feed changes, and environmental exposures. These stressors combine with disease organisms and advance into a complex that challenges an animal’s health. 

In the current scenario, cattle producers are trying to maximize the performance of each animal. Bovine respiratory disease (BRD) is a challenge to all cattle producers. There are many types of infectious agents involved. These agents not only cause severe pneumonia but also swollen, painful joints in calves.  

Few of the promising companies operating in the Asia Pacific Bovine Respiratory Disease Treatment Market are:

  1. Zoetis Inc
  2. Merck & Co. Inc
  3. Bayer Corporation
  4. Eli Lilly & Co
  5. Merial S.A.S
  6. Boehringer Ingelheim Vetmedica
  7. Novartis Animal Health
  8. Vibrac S.A
  9. Ceva Sante Animale
  10. Vétoquinol S.A

This research report segmented and sub-segmented the Asia Pacific Bovine Respiratory Disease Treatment Market into the following categories:

By Treatment Type: Anti – Infectious Agents(antibiotics and sulpha),  Anti – parasiticides, bronchodilators, oral rehydration fluids, non-steroidal anti-inflammatories, and mucolytic.

By Country: Asia Pacific is geographically segmented into China, India, Japan, South Korea, and Australia.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type of Treatment                                            

                                5.1.1 Anti-Infectious Agents                       

                                                5.1.1.1 Antibiotics           

                                                5.1.1.2 Sulfas    

                                5.1.2 Anti-Parasiticides                 

                                5.1.3 Bronchodilators                    

                                5.1.4 Oral Rehydration Fluids                     

                                5.1.5 Non-Steroidal Anti-Inflammatories               

                                5.1.6 Mucolytics                              

6. Geographical Analysis                                                              

                6.3 Asia-Pacific                                 

                                6.1 Introduction                              

                                6.2 China                            

                                6.3 India                              

                                6.4 Japan                            

                                6.5 South Korea               

                                6.6 Australia                      

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8. Market Leaders' Analysis                                                        

                8.1 Zoetis Inc.                                   

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Merck & Co. Inc.                                       

                8.3 Bayer Corporation                                   

                8.4 Eli Lilly & Co.                                              

                8.5 Merial S.A.S                               

                8.6 Boehringer Ingelheim Vetmedica                                     

                8.7 Novartis Animal Health                                          

                8.8 Vibrac S.A                                   

                8.9 Ceva Sante Animale                                

                8.10 Vétoquinol S.A.                                      

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Bovine Respiratory Disease Treatment Market By Region, From 2018–2023 (USD Million)
  2. Asia-Pacific Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  3. Asia-Pacific Anti-Infectious Agents Market By Region, From 2018–2023 (USD Million)
  4. Asia-Pacific Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)
  5. Asia-Pacific Antibiotics Market By Region, From 2018–2023 (USD Million)
  6. Asia-Pacific Sulfas Market By Region, From 2018–2023 (USD Million)
  7. Asia-Pacific Anti-Parasiticides Market By Region, From 2018–2023 (USD Million)
  8. Asia-Pacific Bronchodilators Market By Region, From 2018–2023 (USD Million)
  9. Asia-Pacific Oral Rehydration Fluids Market By Region, From 2018–2023 (USD Million)
  10. Asia-Pacific Non-Steroidal Anti-Inflammatories Market By Region, From 2018–2023 (USD Million)
  11. Asia-Pacific Mucolytic Market By Region, From 2018–2023 (USD Million)
  12. China Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  13. China Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)
  14. India Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  15. India Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)
  16. Japan Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  17. Japan Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)
  18. South Korea Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  19. South Korea Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)
  20. Australia Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  21. Australia Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample